Patel Sushil
Revolution Medicines, Inc. · Director
Patel Sushil serves as a Director at Revolution Medicines, Inc., where he has been involved in various strategic decisions within the healthcare sector. His recent trading activity reflects a focus on sale transactions, with a total of 17 sales reported from July 10, 2024, to July 1, 2026. Notably, his largest disclosed move occurred on April 7, 2026, involving a grant/exercise valued at approximately $2.9 million related to Replimune Group, Inc. (REPL). The disclosed amounts for his sales range from $204.5K to $166.1K, indicating a consistent engagement in the market.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $204k1.1k shares | SellJun 29, 2026 | $185.90 | $184.44 | |
| $170k881 shares | SellJun 29, 2026 | $192.61 | $184.44 | |
| $166k900 shares | SellJun 29, 2026 | $184.59 | $184.44 | |
| $160k858 shares | SellJun 29, 2026 | $186.92 | $184.44 | |
| $114k600 shares | SellJun 29, 2026 | $190.55 | $184.44 | |
| $104k541 shares | SellJun 29, 2026 | $191.87 | $184.44 | |
| $56k300 shares | SellJun 29, 2026 | $187.83 | $184.44 | |
| $55k300 shares | SellJun 29, 2026 | $183.17 | $184.44 | |
| $19k100 shares | SellJun 29, 2026 | $188.57 | $184.44 |